HPV-İlişkili Servikal Kanserin Tedavisine Yönelik İlaç Yüklü Nanopartikül Formülasyonlarının Printing Teknolojisi ile Hazırlanması ve Karakterizasyonu
![](/xmlui/themes/Mirage2//images/mime2.png)
View/ Open
Date
2017-12-06Author
Varan, Cem
xmlui.mirage2.itemSummaryView.MetaData
Show full item recordAbstract
Although clinical applications for the prevention and early detection of cervical
cancer exist, the incidence and the mortality rate is especially high in women living
in developing countries. One of the most important risk factors for cervical cancer,
along with many risk factors, is the human papilloma virus (HPV). Chemotherapy of
HPV-related cervical cancer is very limited. Chemotherapy drugs, which are known
to be effective on this type of cancer, have solubility problems and solubility-related
toxicity. It is needed to develop new drug delivery systems with the aim of preventing
these problems, increasing cellular penetration, protecting drugs against enzymatic
and physiological degradation, and keeping the drug in the application area for a
long time. For this purpose, the development of polymeric nanoparticle based drug
delivery systems is very important. On the other hand, to cervical cancer developing
region can be reached directly by health personnel without the need of surgical
methods and chemotherapy can be applied directly. Taking this into consideration,
the preparation of drug loaded implantable film may increase the treatment success
for cervical cancer and it may also reduce the side-effects seen during treatment.
Disease history, age, sex, genetic and metabolic characteristics of each patient are
different from each other. This leads to the need for appropriate medication and
appropriate dose for the treatment of the patients. For this reason, research on the
development of personalized medicines have been carried out in recent years.
Thanks to printing technology, drug formulations can be prepared easily, quickly and
economically in the desired dose and pattern.
In this thesis, Paclitaxel, which is known to be effective on cervical cancer but has
a solubility problem, was used as model anticancer drug and cidofovir, which is
known to be effective against HPV was used as model antiviral drug. Using the
nanoparticulate drug delivery systems and the cyclodextrin inclusion complex, the
solubility problem of paclitaxel was abolished and controlled release of cidofovir was
achieved. For the purpose of developing a local and personalized drug formulation,
nanoparticulate formulations containing anticancer and antiviral drugs were printed
on a bioadhesive film with adjustable dose and pattern by using ink-jet printers. In
this way, a pharmaceutical formulation containing anticancer and antiviral drug for
the treatment of cervical cancer has been prepared.
In the first part of this thesis, inclusion complexes were formed by using 3 different
cyclodextrin derivatives in order to increase the solubility of paclitaxel and
characterization studies were realized. An encapsulation efficiency of 63% was
achieved with the inclusion complexes prepared with hydroxypropyl-β-cyclodextrin
and this inclusion complex was used to prepare the ink formulation containing
paclitaxel. Likewise, cidofovir loaded nanoparticles based on polycaprolactone were
prepared and characterization studies were carried out. The nanoparticle
formulations prepared with poly (ethylene glycol)-b-poly (ε-caprolactone) methyl
ether showed a particle size of 161 nm and an encapsulation efficiency of 76%. With
the low particle size and high encapsulation efficiency, this nanoparticle formulation
has been used to prepare ink formulations containing cidofovir. In the second part
of the study, ink formulations suitable for printing technique were prepared and
printed on the cellulose-based bioadhesive film with different doses and patterns by
using inclusion complex and nanoparticles. At the end of the thesis, characterization
studies of bioadhesive films printed with drugs, cell culture studies and ex vivo
studies were performed. Cell culture studies showed that the paclitaxel cyclodextrin
inclusion complex printed film reduced cell viability by 50% on HeLa cells and by
45% on C33a cells. In addition, characterization and ex vivo studies have shown
that the printing process enhances the mechanical and bioadhesive properties of
films.
This thesis has taken an important step towards developing an effective, safety, and
personalized drug formulation that carries antiviral and anticancer drugs for the local
treatment of HPV-related cervical cancer.